The Deletion of Hdac4 in Mouse Osteoblasts Influences Both Catabolic and Anabolic Effects in Bone
- 15 March 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 33 (7) , 1362-1375
Abstract
Histone deacetylase 4 (Hdac4) is known to control chondrocyte hypertrophy and bone formation. We have previously shown that parathyroid hormone (PTH) regulates many aspects of Hdac4 function in osteoblastic cells in vitro; however, in vivo confirmation was previously precluded by pre-weaning lethality of the Hdac4 deficient mice. To analyze the function of Hdac4 in bone in mature animals, we generated mice with osteoblast lineage-specific knockout of Hdac4 (Hdac4ob-/-) by crossing transgenic mice expressing Cre recombinase under the control of a 2.3kb fragment of the Col1a1 promoter with mice bearing loxP-Hdac4. The Hdac4ob-/- mice survive to adulthood and developed a mild skeletal phenotype. At 12 weeks of age, they had short, irregularly-shaped and stiff tails due to smaller tail vertebrae, with almost no growth plates. The tibial growth plate zone was also thinned and Mmp13 and Sost mRNAs were increased in the distal femurs of Hdac4ob-/- mice. Immunohistochemistry showed that sclerostin was elevated in Hdac4ob-/- mice, suggesting that Hdac4 inhibits its gene and protein expression. To determine the effect of PTH in these mice, hPTH (1-34) or saline were delivered for 14 days with subcutaneously implanted devices in 8-week-old female Hdac4ob-/- and wild type (Hdac4fl/fl) mice. Serum CTX, a marker of bone resorption, was increased in Hdac4ob-/- mice with or without PTH treatment. Tibial cortical BV/TV, Ct.Th, and relative cortical area (RCA) were decreased in Hdac4ob-/- mice but PTH caused no further decrease in Hdac4ob-/- mice. Tibial trabecular BV/TV and thickness were not changed significantly in Hdac4ob-/- mice but decreased with PTH treatment. These results indicate that Hdac4 inhibits bone resorption and has anabolic effects via inhibiting Mmp13 and Sost/sclerostin expression. Hdac4 influences cortical bone mass and thickness and knockout of Hdac4 prevents the catabolic effect of PTH in cortical bone. This article is protected by copyright. All rights reservedKeywords
Funding Information
- Foundation for the National Institutes of Health (R01DK4720)
This publication has 39 references indexed in Scilit:
- Targeted deletion of Sost distal enhancer increases bone formation and bone massProceedings of the National Academy of Sciences, 2012
- Histone deacetylases in skeletal development and bone mass maintenanceGene, 2011
- HDAC4 Represses Matrix Metalloproteinase-13 Transcription in Osteoblastic Cells, and Parathyroid Hormone Controls This RepressionJournal of Biological Chemistry, 2010
- Structural basis of growth-related gain and age-related loss of bone strength Proceedings of a satellite symposium held on the occasion of the EULAR Congress, Paris, France, June 13, 2008Rheumatology, 2008
- Control of the SOST Bone Enhancer by PTH Using MEF2 Transcription FactorsJournal of Bone and Mineral Research, 2007
- Overexpression of Runx2 directed by the matrix metalloproteinase‐13 promoter containing the AP‐1 and Runx/RD/Cbfa sites alters bone remodeling in vivoJournal of Cellular Biochemistry, 2006
- Parathyroid hormone — a bone anabolic and catabolic agentCurrent Opinion in Pharmacology, 2005
- Short-term continuous infusion of human parathyroid hormone 1–34 fragment is catabolic with decreased trabecular connectivity density accompanied by hypercalcemia in C57BL/J6 miceJournal of Endocrinology, 2005
- Continuous Parathyroid Hormone and Estrogen Administration Increases Vertebral Cancellous Bone Volume and Cortical Width in the Estrogen-Deficient RatJournal of Bone and Mineral Research, 2001
- Cbfa1 Contributes to the Osteoblast-specific Expression of type I collagen GenesJournal of Biological Chemistry, 2001